BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 27781389)

  • 1. Genetic variants associated with risk of Alzheimer's disease contribute to cognitive change in midlife: The Atherosclerosis Risk in Communities Study.
    Bressler J; Mosley TH; Penman A; Gottesman RF; Windham BG; Knopman DS; Wruck LM; Boerwinkle E
    Am J Med Genet B Neuropsychiatr Genet; 2017 Apr; 174(3):269-282. PubMed ID: 27781389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics and cognition in African American adults in midlife: the atherosclerosis risk in communities study.
    Bressler J; Yu B; Mosley TH; Knopman DS; Gottesman RF; Alonso A; Sharrett AR; Wruck LM; Boerwinkle E
    Transl Psychiatry; 2017 Jul; 7(7):e1173. PubMed ID: 28934192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late-onset epilepsy and 25-year cognitive change: The Atherosclerosis Risk in Communities (ARIC) study.
    Johnson EL; Krauss GL; Walker KA; Brandt J; Kucharska-Newton A; Mosley TH; Yasar S; Gottesman RF
    Epilepsia; 2020 Aug; 61(8):1764-1773. PubMed ID: 32710450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma phospholipid very-long-chain SFAs in midlife and 20-year cognitive change in the Atherosclerosis Risk in Communities (ARIC): a cohort study.
    Li D; Misialek JR; Jing M; Tsai MY; Eckfeldt JH; Steffen LM; Knopman D; Wruck L; Gottesman R; Mosley TH; Sharrett AR; Alonso A
    Am J Clin Nutr; 2020 Jun; 111(6):1252-1258. PubMed ID: 32320012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fat mass and obesity gene and cognitive decline: the Atherosclerosis Risk in Communities Study.
    Bressler J; Fornage M; Demerath EW; Knopman DS; Monda KL; North KE; Penman A; Mosley TH; Boerwinkle E
    Neurology; 2013 Jan; 80(1):92-9. PubMed ID: 23136261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk.
    Ebbert MTW; Boehme KL; Wadsworth ME; Staley LA; ; ; Mukherjee S; Crane PK; Ridge PG; Kauwe JSK
    Alzheimers Dement; 2016 Feb; 12(2):121-129. PubMed ID: 26449541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population: cohort studies and meta-analyses of 362,338 individuals.
    Nordestgaard LT; Tybjærg-Hansen A; Rasmussen KL; Nordestgaard BG; Frikke-Schmidt R
    BMC Med; 2018 Mar; 16(1):39. PubMed ID: 29534716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of memory endophenotypes for association with CLU, CR1, and PICALM variants in black and white subjects.
    Pedraza O; Allen M; Jennette K; Carrasquillo M; Crook J; Serie D; Pankratz VS; Palusak R; Nguyen T; Malphrus K; Ma L; Bisceglio G; Roberts RO; Lucas JA; Ivnik RJ; Smith GE; Graff-Radford NR; Petersen RC; Younkin SG; Ertekin-Taner N
    Alzheimers Dement; 2014 Mar; 10(2):205-13. PubMed ID: 23643458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of Cognitive Test Score Decline Prior to Incident Dementia Diagnosis in Blacks and Whites: The Atherosclerosis Risk in Communities Neurocognitive Study.
    Wang Y; Sharrett AR; Schneider ALC; Knopman D; Hu J; Gottesman R; Sullivan KJ; Coresh J
    Neuroepidemiology; 2024; 58(1):23-30. PubMed ID: 37918374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the Haptoglobin Gene Polymorphism With Cognitive Function and Decline in Elderly African American Adults With Type 2 Diabetes: Findings From the Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Study.
    Beeri MS; Lin HM; Sano M; Ravona-Springer R; Liu X; Bendlin BB; Gleason CE; Guerrero-Berroa E; Soleimani L; Launer LJ; Ehrenberg S; Lache O; Seligman YK; Levy AP
    JAMA Netw Open; 2018 Nov; 1(7):e184458. PubMed ID: 30646354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D and cognitive function and dementia risk in a biracial cohort: the ARIC Brain MRI Study.
    Schneider AL; Lutsey PL; Alonso A; Gottesman RF; Sharrett AR; Carson KA; Gross M; Post WS; Knopman DS; Mosley TH; Michos ED
    Eur J Neurol; 2014 Sep; 21(9):1211-8, e69-70. PubMed ID: 24846449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-sensitivity cardiac troponin T and cognitive function and dementia risk: the atherosclerosis risk in communities study.
    Schneider AL; Rawlings AM; Sharrett AR; Alonso A; Mosley TH; Hoogeveen RC; Ballantyne CM; Gottesman RF; Selvin E
    Eur Heart J; 2014 Jul; 35(27):1817-24. PubMed ID: 24685712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOE ε4 and the risk for Alzheimer disease and cognitive decline in African Americans and Yoruba.
    Hendrie HC; Murrell J; Baiyewu O; Lane KA; Purnell C; Ogunniyi A; Unverzagt FW; Hall K; Callahan CM; Saykin AJ; Gureje O; Hake A; Foroud T; Gao S
    Int Psychogeriatr; 2014 Jun; 26(6):977-85. PubMed ID: 24565289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late Onset Alzheimer's Disease Risk Variants in Cognitive Decline: The PATH Through Life Study.
    Andrews SJ; Das D; Anstey KJ; Easteal S
    J Alzheimers Dis; 2017; 57(2):423-436. PubMed ID: 28269768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Alzheimer's related genotypes with cognitive decline in multiple domains: results from the Three-City Dijon study.
    Vivot A; Glymour MM; Tzourio C; Amouyel P; Chêne G; Dufouil C
    Mol Psychiatry; 2015 Oct; 20(10):1173-8. PubMed ID: 26033242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study.
    Gottesman RF; Schneider AL; Albert M; Alonso A; Bandeen-Roche K; Coker L; Coresh J; Knopman D; Power MC; Rawlings A; Sharrett AR; Wruck LM; Mosley TH
    JAMA Neurol; 2014 Oct; 71(10):1218-27. PubMed ID: 25090106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease genes and cognition in the nondemented general population.
    Verhaaren BF; Vernooij MW; Koudstaal PJ; Uitterlinden AG; van Duijn CM; Hofman A; Breteler MM; Ikram MA
    Biol Psychiatry; 2013 Mar; 73(5):429-34. PubMed ID: 22592056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral MRI findings and cognitive functioning: the Atherosclerosis Risk in Communities study.
    Mosley TH; Knopman DS; Catellier DJ; Bryan N; Hutchinson RG; Grothues CA; Folsom AR; Cooper LS; Burke GL; Liao D; Szklo M
    Neurology; 2005 Jun; 64(12):2056-62. PubMed ID: 15985571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Alzheimer's genetic loci with mild behavioral impairment.
    Andrews SJ; Ismail Z; Anstey KJ; Mortby M
    Am J Med Genet B Neuropsychiatr Genet; 2018 Dec; 177(8):727-735. PubMed ID: 30378268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Episodic Memory and Genetic Risk Factors for Alzheimer's Disease in South Asians from the Longitudinal Aging Study in India-Diagnostic Assessment of Dementia (LASI-DAD).
    Smith JA; Zhao W; Yu M; Rumfelt KE; Moorjani P; Ganna A; Dey AB; Lee J; Kardia SLR
    J Am Geriatr Soc; 2020 Aug; 68 Suppl 3(Suppl 3):S45-S53. PubMed ID: 32815605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.